Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AstraZeneca Has Dazzled in Recent Cancer Trials, but Faces Stiff Competition
BioSpace
Thu, 06/27/19 - 06:38 pm
Tags:
AstraZeneca, clinical trials, Imfinzi, extensive-stage small cell lung cancer, Calquence, CLL
AZ’s Imfinzi on target in small cell lung cancer, sets up Roche rivalry
Pharmaforum
Thu, 06/27/19 - 09:34 am
Tags:
AstraZeneca, Imfinzi, extensive-stage small cell lung cancer, Roche, Tecentriq
Abbvie proves the best at getting the most out of its workers
EP Vantage
Fri, 06/21/19 - 09:44 am
Tags:
AbbVie, Bristol-Myers Squibb, Sanofi, AstraZeneca, revenue per employee
AstraZeneca's Lynparza gets EU nod as first-line ovarian cancer maintenance treatment
Yahoo/Reuters
Tue, 06/18/19 - 10:04 am
Tags:
AstraZeneca, Lynparza, ovarian cancer, Europe
AstraZeneca's Calquence sets Imbruvica in its sights with big CLL survival numbers
Fierce Pharma
Mon, 06/17/19 - 11:21 pm
Tags:
AstraZeneca, Calquence, CLL, Imbruvica
AstraZeneca spinout Viela Bio pockets $75M on its way to BLA for autoimmune drug
Endpoints
Mon, 06/17/19 - 12:21 pm
Tags:
Viela Bio, AstraZeneca, autoimmune disease
AstraZeneca commits $630M to Korean drug R&D push
Fierce Biotech
Mon, 06/17/19 - 09:58 am
Tags:
AstraZeneca, South Korea, R&D, Sweden
AstraZeneca’s Lokelma shows significant effect in ESRD trial
Pharmaceutical Business Review
Mon, 06/17/19 - 09:51 am
Tags:
AstraZeneca, Lokelma, hyperkalaemia, renal disease
Plagued by delays, AstraZeneca HQ costs soar to £750M as it edges toward 2020 completion
Endpoints
Wed, 06/12/19 - 09:38 am
Tags:
AstraZeneca, headquarters
ADA: AstraZeneca's Farxiga scores in kidney outcomes study
Fierce Pharma
Mon, 06/10/19 - 09:44 am
Tags:
AstraZeneca, ADA, Farxiga, clinical trials, renal disease
AstraZeneca ends another Calquence trial early
Pharmaforum
Thu, 06/6/19 - 09:55 am
Tags:
AstraZeneca, CLL, Calquence, clinical trials
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More
Xconomy
Wed, 06/5/19 - 10:43 am
Tags:
ASCO 2019, cancer, immunotherapy, diagnostics, Veracyte, Grail, Moderna Therapeutics, Amgen, Nektar Therapeutics, Blueprint Medicines, Merck, AstraZeneca, Roche, breast cancer
ASCO Soundbites, vol. 3: Real-time approvals, Pfizer's second rodeo and 'the busiest ASCO ever'
Fierce Pharma
Tue, 06/4/19 - 12:18 pm
Tags:
ASCO 2019, Merck, Keytruda, FDA, Pfizer, AstraZeneca, Regeneron, Libtayo, Venclexta, Gazyva
AstraZeneca scouts replacements for longtime chairman Johansson: report
Fierce Pharma
Tue, 06/4/19 - 11:05 am
Tags:
AstraZeneca, Leif Johansson
ASCO 2019 – The results of clinical practices changing phase III studies
Pharmaforum
Mon, 06/3/19 - 11:32 pm
Tags:
clinical trials, ASCO 2019, Merck, AstraZeneca
Imfinzi demonstrates overall survival at three years in unresectable stage III NSCLC
Pharmaceutical Business Review
Mon, 06/3/19 - 11:29 am
Tags:
AstraZeneca, Imfinzi, ASCO 2019, non-small cell lung cancer
ASCO 2019 day three
Pharmaforum
Sun, 06/2/19 - 01:09 pm
Tags:
ASCO 2019, Merck, AstraZeneca, pancreatic cancer, Novartis, alpelisib, Roche, entrectinib
AZ/Merck & Co reveal data supporting PARP drug in prostate cancer
Pharmaforum
Sat, 06/1/19 - 12:43 pm
Tags:
ASCO 2019, AstraZeneca, Merck, prostate cancer, olaparib
ASCO 2019 day one
Pharmaforum
Fri, 05/31/19 - 11:46 am
Tags:
ASCO 2019, JNJ, Erleada, AstraZeneca, Merck, Lynparza, prostate cancer
ASCO 2019 Preview: Presentations to Keep An Eye On
BioSpace
Thu, 05/30/19 - 09:35 am
Tags:
ASCO 2019, Novartis, Oncoceutics, OncoNano Medicine, AstraZeneca

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.